首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性肝癌并门静脉癌栓的肝动脉化疗栓塞治疗
引用本文:李凯滨,黄肇云,罗剑云,陈亚炎.原发性肝癌并门静脉癌栓的肝动脉化疗栓塞治疗[J].中华普通外科杂志,2005,20(12):768-770.
作者姓名:李凯滨  黄肇云  罗剑云  陈亚炎
作者单位:526021,广东省肇庆市第一人民医院肿瘤科
摘    要:目的评价经肝动脉化疗栓塞术治疗原发性肝癌并门静脉癌栓的疗效和安全性。方法原发性肝癌并门静脉癌栓患者83例,其中53例行肝动脉化疗栓塞术(栓塞组),30例行肝动脉化学药物灌注(对照组)。对两组的疗效和并发症进行比较。结果经介入治疗后,栓塞组患者 6、12、24、36个月的生存率分别为97.8%、85.2%、45.8%、4.4%,均高于对照组(37.6%、5.3%、0、0. P均<0.01)。两组患者术后并发症的发生率差异无统计学意义。结论原发性肝癌并门静脉癌栓行经肝动脉化疗栓塞术较化疗灌注术的疗效好。

关 键 词:  肝细胞  门静脉  癌栓  放射学  介入治疗性
收稿时间:2005-03-11
修稿时间:2005年3月11日

Trans-arterial chemotherapy and embolization for the treatment of primary hepatic carcinoma complicated with portal vein tumor thrombus
LI Kai-bin,HUANG Zhao-yun,LUO Jian-yun,CHEN Ya-yan.Trans-arterial chemotherapy and embolization for the treatment of primary hepatic carcinoma complicated with portal vein tumor thrombus[J].Chinese Journal of General Surgery,2005,20(12):768-770.
Authors:LI Kai-bin  HUANG Zhao-yun  LUO Jian-yun  CHEN Ya-yan
Abstract:Objective To evaluate the effect and safety of trans-arterial chemotherapy embolization (TACE) in the treatment of primary hepatic carcinoma ( PHC ) with portal vein tumor thrombus. Methods There were 83 PHC patients complicated with portal vein tumor thrombus, age ranging from 29 to 76 years. Fifty-three cases underwent TACE ( Group A) , 30 receiving trans-arterial chemotherapy infusion only (TAI, Group B). Results The survival rate in group A at 6,12,24 and 36 months was 97. 8% , 85.2%,45.8% and 4.4%, respectively, significantly higher than that in group B (37. 6% ,5. 3% ,0,0, P <0.01). Complication rate was similar between the two groups. Conclusion TACE is more effective than TAI for the treatment of PHC with portal vein tumor thrombus.
Keywords:Carcinoma  hepatocellular  Portal vein  Tumor thrombi  Radiology  interventional
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号